uric acid has been researched along with ro13-9904 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barré, J; Brandebourger, M; Hamberger, C; Pochet, I; Tillement, JP | 1 |
Daneshmand, H; Gharib, A; Ghojevand, N; Karimi, A; Khatami, A; Mohkam, M; Sharifian, M | 1 |
Akl, KF; Hjazeen, MM; Masri, AT | 1 |
Abdel-Daim, MM; El-Ghoneimy, A | 1 |
Abdel-Daim, MM; El-Sayed, YS; Eldaim, MA; Ibrahim, A | 1 |
5 other study(ies) available for uric acid and ro13-9904
Article | Year |
---|---|
[In vitro study of ceftriaxone binding to blood].
Topics: Bilirubin; Binding Sites; Blood Proteins; Ceftriaxone; Erythrocytes; Humans; Oleic Acid; Oleic Acids; Serum Albumin; Uric Acid | 1986 |
Ceftriaxone associated nephrolithiasis: a prospective study in 284 children.
Topics: Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Creatinine; Cystine; Female; Humans; Infant; Infusions, Intravenous; Male; Nephrolithiasis; Prospective Studies; Radiography; Ultrasonography; Uric Acid | 2007 |
Acute urine retention induced by ceftriaxone.
Topics: Acute Disease; Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Humans; Male; Meningitis; Uric Acid; Urinary Retention | 2011 |
Synergistic protective effects of ceftriaxone and ascorbic acid against subacute deltamethrin-induced nephrotoxicity in rats.
Topics: Acetylcholinesterase; Animals; Antioxidants; Ascorbic Acid; Ceftriaxone; Creatinine; Disease Models, Animal; Insecticides; Kidney Diseases; Lipid Peroxidation; Male; Nitriles; Oxidative Stress; Protective Agents; Pyrethrins; Rats; Rats, Wistar; Treatment Outcome; Tumor Necrosis Factor-alpha; Uric Acid | 2015 |
Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats.
Topics: Actins; Animals; Biomarkers; Bromodeoxyuridine; Ceftriaxone; Cell Proliferation; Cisplatin; Creatinine; Cytoprotection; Disease Models, Animal; Fibrosis; Kidney; Kidney Diseases; Male; Protective Agents; Rats, Wistar; Transforming Growth Factor beta1; Urea; Uric Acid | 2017 |